Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chagas Disease | 26 | 2025 | 309 | 6.760 |
Why?
|
| Trypanosoma cruzi | 26 | 2025 | 251 | 6.640 |
Why?
|
| Chagas Cardiomyopathy | 6 | 2021 | 51 | 2.340 |
Why?
|
| Vaccines | 6 | 2023 | 381 | 1.960 |
Why?
|
| Nitroimidazoles | 5 | 2023 | 48 | 1.920 |
Why?
|
| Facial Nerve Injuries | 5 | 2022 | 7 | 1.810 |
Why?
|
| Trypanocidal Agents | 4 | 2023 | 33 | 1.740 |
Why?
|
| Antibodies, Protozoan | 6 | 2025 | 97 | 1.720 |
Why?
|
| Protozoan Vaccines | 11 | 2024 | 98 | 1.700 |
Why?
|
| Motor Neurons | 6 | 2022 | 122 | 1.600 |
Why?
|
| Facial Nucleus | 2 | 2022 | 2 | 1.220 |
Why?
|
| Antibody Formation | 3 | 2025 | 267 | 0.940 |
Why?
|
| Amyotrophic Lateral Sclerosis | 3 | 2018 | 173 | 0.890 |
Why?
|
| Parasites | 2 | 2023 | 35 | 0.850 |
Why?
|
| Superoxide Dismutase | 2 | 2015 | 170 | 0.840 |
Why?
|
| Antigens, Protozoan | 5 | 2024 | 80 | 0.790 |
Why?
|
| Ascaris suum | 3 | 2020 | 32 | 0.760 |
Why?
|
| Animals | 43 | 2025 | 33176 | 0.760 |
Why?
|
| Mice | 26 | 2025 | 17667 | 0.710 |
Why?
|
| Facial Nerve | 2 | 2018 | 25 | 0.670 |
Why?
|
| Mice, Inbred BALB C | 13 | 2025 | 1001 | 0.660 |
Why?
|
| Monkey Diseases | 1 | 2020 | 16 | 0.650 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2019 | 21 | 0.630 |
Why?
|
| Protozoan Proteins | 4 | 2024 | 132 | 0.630 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2019 | 42 | 0.630 |
Why?
|
| Lymphokines | 1 | 2019 | 64 | 0.620 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 216 | 0.620 |
Why?
|
| Microbiota | 2 | 2023 | 426 | 0.600 |
Why?
|
| Protective Agents | 1 | 2018 | 36 | 0.570 |
Why?
|
| Immunity, Cellular | 2 | 2022 | 196 | 0.560 |
Why?
|
| HLA-A Antigens | 1 | 2018 | 31 | 0.560 |
Why?
|
| HLA-B Antigens | 1 | 2018 | 25 | 0.560 |
Why?
|
| Myocardium | 2 | 2019 | 845 | 0.550 |
Why?
|
| Immunoglobulin G | 3 | 2022 | 773 | 0.530 |
Why?
|
| Central Nervous System Diseases | 1 | 2018 | 94 | 0.530 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 445 | 0.520 |
Why?
|
| Ascariasis | 4 | 2020 | 73 | 0.510 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 619 | 0.510 |
Why?
|
| Immunologic Memory | 1 | 2018 | 194 | 0.500 |
Why?
|
| Mice, Inbred C57BL | 8 | 2025 | 4513 | 0.480 |
Why?
|
| Vaccination | 8 | 2022 | 1004 | 0.450 |
Why?
|
| Axotomy | 3 | 2022 | 12 | 0.440 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 479 | 0.400 |
Why?
|
| Leishmania | 2 | 2023 | 32 | 0.390 |
Why?
|
| Leishmaniasis | 2 | 2023 | 39 | 0.390 |
Why?
|
| Disease Models, Animal | 8 | 2025 | 4442 | 0.380 |
Why?
|
| Nerve Regeneration | 2 | 2019 | 71 | 0.380 |
Why?
|
| Interleukin-10 | 3 | 2022 | 181 | 0.370 |
Why?
|
| Heart | 5 | 2023 | 650 | 0.360 |
Why?
|
| Recombinant Proteins | 5 | 2023 | 1295 | 0.340 |
Why?
|
| Antigens, Helminth | 5 | 2020 | 187 | 0.340 |
Why?
|
| Trichuriasis | 3 | 2022 | 31 | 0.330 |
Why?
|
| Immunization | 5 | 2022 | 303 | 0.320 |
Why?
|
| Female | 23 | 2025 | 68570 | 0.320 |
Why?
|
| Antibodies, Helminth | 3 | 2020 | 131 | 0.310 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2022 | 440 | 0.300 |
Why?
|
| B-Lymphocytes | 4 | 2025 | 516 | 0.280 |
Why?
|
| Fibrosis | 2 | 2019 | 400 | 0.270 |
Why?
|
| Superantigens | 2 | 2017 | 20 | 0.250 |
Why?
|
| Wallerian Degeneration | 1 | 2006 | 8 | 0.250 |
Why?
|
| Adjuvants, Immunologic | 5 | 2022 | 380 | 0.240 |
Why?
|
| Cytokines | 4 | 2022 | 1324 | 0.240 |
Why?
|
| RNA, Messenger | 3 | 2024 | 2540 | 0.240 |
Why?
|
| Superoxide Dismutase-1 | 2 | 2016 | 25 | 0.230 |
Why?
|
| Hepatomegaly | 1 | 2023 | 22 | 0.210 |
Why?
|
| Disease Progression | 3 | 2023 | 2117 | 0.210 |
Why?
|
| PPAR alpha | 1 | 2023 | 53 | 0.210 |
Why?
|
| Leishmania mexicana | 1 | 2023 | 3 | 0.200 |
Why?
|
| Interferon-gamma | 4 | 2019 | 527 | 0.200 |
Why?
|
| Mutation | 2 | 2017 | 5947 | 0.190 |
Why?
|
| Th2 Cells | 2 | 2017 | 186 | 0.190 |
Why?
|
| Immunoglobulin M | 3 | 2018 | 210 | 0.190 |
Why?
|
| Neuroprotection | 1 | 2022 | 28 | 0.190 |
Why?
|
| Th1 Cells | 2 | 2022 | 154 | 0.190 |
Why?
|
| RNA, Protozoan | 1 | 2021 | 10 | 0.180 |
Why?
|
| Metabolome | 2 | 2021 | 316 | 0.170 |
Why?
|
| Mice, Transgenic | 3 | 2016 | 2311 | 0.170 |
Why?
|
| Parasite Load | 2 | 2018 | 31 | 0.170 |
Why?
|
| Larva | 2 | 2018 | 249 | 0.170 |
Why?
|
| Tropism | 1 | 2020 | 9 | 0.170 |
Why?
|
| Antigenic Variation | 1 | 2021 | 37 | 0.170 |
Why?
|
| Humans | 22 | 2024 | 127180 | 0.170 |
Why?
|
| Mexico | 2 | 2018 | 193 | 0.160 |
Why?
|
| Interleukin-17 | 1 | 2021 | 124 | 0.160 |
Why?
|
| Flow Cytometry | 2 | 2023 | 754 | 0.160 |
Why?
|
| Phospholipids | 1 | 2020 | 99 | 0.160 |
Why?
|
| Seroepidemiologic Studies | 1 | 2020 | 140 | 0.160 |
Why?
|
| Endothelin-1 | 1 | 2019 | 40 | 0.160 |
Why?
|
| Cysteine | 2 | 2017 | 137 | 0.160 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2020 | 137 | 0.150 |
Why?
|
| Parasitemia | 1 | 2019 | 26 | 0.150 |
Why?
|
| Male Urogenital Diseases | 1 | 2019 | 15 | 0.150 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2018 | 341 | 0.150 |
Why?
|
| Helminth Proteins | 1 | 2020 | 103 | 0.150 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2019 | 35 | 0.150 |
Why?
|
| Mice, Inbred ICR | 1 | 2019 | 152 | 0.150 |
Why?
|
| Antibodies, Catalytic | 1 | 2018 | 7 | 0.150 |
Why?
|
| Macaca mulatta | 1 | 2020 | 480 | 0.150 |
Why?
|
| Swine Diseases | 1 | 2018 | 40 | 0.150 |
Why?
|
| Electric Stimulation Therapy | 1 | 2019 | 79 | 0.140 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2019 | 173 | 0.140 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2018 | 20 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 787 | 0.140 |
Why?
|
| Immunity | 1 | 2018 | 175 | 0.140 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2018 | 131 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 2 | 2018 | 1484 | 0.130 |
Why?
|
| Spinal Cord | 1 | 2018 | 248 | 0.130 |
Why?
|
| Cell Death | 1 | 2018 | 234 | 0.130 |
Why?
|
| Immunophenotyping | 1 | 2018 | 330 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 972 | 0.130 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2018 | 199 | 0.130 |
Why?
|
| Host-Parasite Interactions | 1 | 2016 | 71 | 0.120 |
Why?
|
| Recovery of Function | 1 | 2018 | 439 | 0.120 |
Why?
|
| Vaccines, Synthetic | 4 | 2022 | 316 | 0.120 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2017 | 143 | 0.120 |
Why?
|
| Trichuris | 3 | 2022 | 26 | 0.120 |
Why?
|
| Insect Vectors | 1 | 2016 | 106 | 0.120 |
Why?
|
| Gene Frequency | 1 | 2018 | 738 | 0.120 |
Why?
|
| Mice, Knockout | 2 | 2022 | 3711 | 0.120 |
Why?
|
| Fibroblasts | 1 | 2019 | 820 | 0.120 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 1596 | 0.120 |
Why?
|
| Laser Capture Microdissection | 1 | 2015 | 8 | 0.120 |
Why?
|
| Motor Disorders | 1 | 2015 | 5 | 0.120 |
Why?
|
| Cell Survival | 1 | 2018 | 837 | 0.120 |
Why?
|
| Motor Activity | 1 | 2018 | 504 | 0.120 |
Why?
|
| Sensation Disorders | 1 | 2015 | 24 | 0.120 |
Why?
|
| Th17 Cells | 1 | 2016 | 93 | 0.110 |
Why?
|
| Spinal Cord Injuries | 1 | 2018 | 274 | 0.110 |
Why?
|
| Swine | 1 | 2018 | 1173 | 0.110 |
Why?
|
| Muscle Strength | 1 | 2015 | 79 | 0.110 |
Why?
|
| Acute Disease | 1 | 2018 | 1140 | 0.110 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 610 | 0.110 |
Why?
|
| Echocardiography | 1 | 2019 | 1114 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2023 | 680 | 0.100 |
Why?
|
| Transfection | 1 | 2015 | 948 | 0.100 |
Why?
|
| Vaccines, Combined | 2 | 2023 | 39 | 0.100 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 228 | 0.100 |
Why?
|
| Histamine Release | 1 | 2012 | 10 | 0.100 |
Why?
|
| Basophils | 1 | 2012 | 12 | 0.100 |
Why?
|
| Hookworm Infections | 1 | 2014 | 125 | 0.100 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2012 | 28 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 1 | 2018 | 1709 | 0.090 |
Why?
|
| Immunotherapy | 1 | 2017 | 741 | 0.090 |
Why?
|
| Necator americanus | 1 | 2012 | 91 | 0.090 |
Why?
|
| Genotype | 1 | 2018 | 2598 | 0.090 |
Why?
|
| HIV Infections | 1 | 2024 | 1953 | 0.090 |
Why?
|
| Global Health | 1 | 2016 | 609 | 0.090 |
Why?
|
| Immunoglobulin E | 1 | 2012 | 220 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2018 | 1508 | 0.090 |
Why?
|
| Male | 5 | 2020 | 62757 | 0.090 |
Why?
|
| Lung | 1 | 2018 | 1522 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2018 | 2394 | 0.080 |
Why?
|
| Biomarkers | 1 | 2019 | 3234 | 0.080 |
Why?
|
| Interleukin-4 | 2 | 2022 | 144 | 0.080 |
Why?
|
| Feeding Behavior | 1 | 2015 | 707 | 0.080 |
Why?
|
| Age Factors | 1 | 2015 | 2800 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3695 | 0.070 |
Why?
|
| Leishmania major | 1 | 2007 | 27 | 0.070 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2007 | 48 | 0.070 |
Why?
|
| Pregnancy | 1 | 2020 | 7380 | 0.070 |
Why?
|
| Soil | 2 | 2020 | 73 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 1891 | 0.060 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2006 | 56 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2007 | 219 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 422 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 1 | 2007 | 363 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2024 | 109 | 0.050 |
Why?
|
| Technology | 1 | 2024 | 69 | 0.050 |
Why?
|
| Dogs | 2 | 2016 | 614 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 671 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2024 | 363 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2017 | 1495 | 0.050 |
Why?
|
| Campylobacter jejuni | 1 | 2003 | 6 | 0.050 |
Why?
|
| Campylobacter Infections | 1 | 2003 | 33 | 0.050 |
Why?
|
| HIV | 1 | 2024 | 171 | 0.050 |
Why?
|
| Sus scrofa | 1 | 2003 | 114 | 0.050 |
Why?
|
| Antiparasitic Agents | 1 | 2022 | 28 | 0.050 |
Why?
|
| Mice, Inbred AKR | 1 | 2022 | 15 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2024 | 512 | 0.050 |
Why?
|
| Mucous Membrane | 1 | 2022 | 86 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2020 | 17045 | 0.050 |
Why?
|
| Administration, Intranasal | 1 | 2022 | 130 | 0.050 |
Why?
|
| Immunity, Mucosal | 1 | 2022 | 83 | 0.040 |
Why?
|
| Hybridomas | 1 | 2021 | 38 | 0.040 |
Why?
|
| Synteny | 1 | 2021 | 69 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 205 | 0.040 |
Why?
|
| Epitopes | 1 | 2022 | 420 | 0.040 |
Why?
|
| RNA | 1 | 2024 | 519 | 0.040 |
Why?
|
| Colon | 1 | 2003 | 353 | 0.040 |
Why?
|
| Multigene Family | 1 | 2021 | 289 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2021 | 989 | 0.040 |
Why?
|
| Aged | 1 | 2018 | 20410 | 0.040 |
Why?
|
| Neurotrophin 3 | 1 | 2018 | 13 | 0.040 |
Why?
|
| Thoracic Vertebrae | 1 | 2018 | 66 | 0.040 |
Why?
|
| Schwann Cells | 1 | 2018 | 56 | 0.030 |
Why?
|
| Middle Aged | 1 | 2018 | 27785 | 0.030 |
Why?
|
| Phylogeny | 1 | 2020 | 687 | 0.030 |
Why?
|
| Neuromuscular Junction | 1 | 2018 | 92 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 2017 | 51 | 0.030 |
Why?
|
| Cholera Toxin | 1 | 2017 | 43 | 0.030 |
Why?
|
| Models, Animal | 1 | 2019 | 452 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 2017 | 49 | 0.030 |
Why?
|
| Dependovirus | 1 | 2018 | 144 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2017 | 140 | 0.030 |
Why?
|
| Dendrites | 1 | 2018 | 174 | 0.030 |
Why?
|
| Coyotes | 1 | 2016 | 3 | 0.030 |
Why?
|
| Adult | 1 | 2018 | 30511 | 0.030 |
Why?
|
| Animals, Domestic | 1 | 2016 | 37 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2017 | 116 | 0.030 |
Why?
|
| Triatoma | 1 | 2016 | 27 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2017 | 283 | 0.030 |
Why?
|
| T-Lymphocytopenia, Idiopathic CD4-Positive | 1 | 2016 | 2 | 0.030 |
Why?
|
| Serine | 1 | 2017 | 160 | 0.030 |
Why?
|
| Housing | 1 | 2016 | 71 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2018 | 321 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 404 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 586 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 327 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1852 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 2543 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 1125 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2016 | 332 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2015 | 199 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2017 | 573 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2017 | 396 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2017 | 435 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2016 | 283 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2017 | 395 | 0.030 |
Why?
|
| Ascaris lumbricoides | 1 | 2014 | 19 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2017 | 891 | 0.030 |
Why?
|
| Anthelmintics | 1 | 2014 | 55 | 0.030 |
Why?
|
| Ancylostomatoidea | 1 | 2014 | 62 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2892 | 0.020 |
Why?
|
| Alum Compounds | 1 | 2012 | 42 | 0.020 |
Why?
|
| Pichia | 1 | 2012 | 56 | 0.020 |
Why?
|
| Vaccines, Subunit | 1 | 2012 | 71 | 0.020 |
Why?
|
| Cricetinae | 1 | 2012 | 365 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2012 | 156 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 973 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 2612 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 2012 | 225 | 0.020 |
Why?
|
| Skin | 1 | 2012 | 517 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3324 | 0.020 |
Why?
|
| United States | 1 | 2024 | 11359 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 3564 | 0.020 |
Why?
|
| Gene Expression | 1 | 2012 | 1485 | 0.020 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2007 | 13 | 0.020 |
Why?
|
| Ear | 1 | 2007 | 27 | 0.020 |
Why?
|
| Dermis | 1 | 2007 | 23 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2312 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2007 | 120 | 0.020 |
Why?
|
| Interleukin-13 | 1 | 2007 | 94 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2007 | 374 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 309 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12564 | 0.010 |
Why?
|
| Inflammation | 1 | 2007 | 1427 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 3264 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2007 | 4480 | 0.010 |
Why?
|